Barbara Ann Karmanos Cancer Center — Detroit, Michigan

Barbara Ann Karmanos Cancer Center is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

Barbara Ann Karmanos Cancer Center has participated in 17 clinical trials with 3 currently active.

Therapeutic areas: Related Hematopoietic Stem Cell Donors, Hormone Receptor Positive Malignant Neoplasm of Breast, Multiple Myeloma.

Sponsors: Center for International Blood and Marrow Transplant Research, Stemline Therapeutics, Inc., Takeda.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Detroit

Browse all research sites in Michigan · View every site in Detroit

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Barbara Ann Karmanos Cancer Center?

Barbara Ann Karmanos Cancer Center has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Barbara Ann Karmanos Cancer Center conducted?

Barbara Ann Karmanos Cancer Center has 17 clinical trials on record, with 3 currently active. Their work covers Related Hematopoietic Stem Cell Donors, Hormone Receptor Positive Malignant Neoplasm of Breast, Multiple Myeloma.

Is Barbara Ann Karmanos Cancer Center accredited by Crixeo Clinical Trials?

Barbara Ann Karmanos Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Barbara Ann Karmanos Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.